Study Type

RCT

Context

This study addresses the uncertainty regarding the efficacy of n-3 polyunsaturated fatty acid supplementation for cardiovascular event prevention in patients receiving maintenance hemodialysis.

Finding

Daily supplementation with fish oil (4 g of n-3 polyunsaturated fatty acids) significantly reduced the rate of serious cardiovascular events compared to placebo (hazard ratio 0.57; 95% CI, 0.47 to 0.70; P<0.001) over 3.5 years of follow-up.

So What?

Clinicians managing patients on hemodialysis should consider fish oil supplementation as it significantly lowers serious cardiovascular events, a leading cause of mortality in this population.

Study Type

RCT

Context

This study examined whether evolocumab reduces the risk of major adverse cardiovascular events in patients with atherosclerosis or diabetes but without a previous myocardial infarction or stroke.

Finding

Evolocumab significantly reduced the risk of 3-point MACE (hazard ratio 0.75; 95% CI, 0.65 to 0.86; P<0.001) and 4-point MACE (hazard ratio 0.81; 95% CI, 0.73 to 0.89; P<0.001) compared to placebo over a median follow-up of 4.6 years, with no difference in safety events.

So What?

Clinicians should consider PCSK9 inhibition with evolocumab to lower the risk of first cardiovascular events in patients with atherosclerosis or diabetes even if they have no prior myocardial infarction or stroke.

Study Type

RCT

Context

This study addresses whether adding carotid revascularization (stenting or endarterectomy) to intensive medical management provides greater benefit than medical management alone in patients with high-grade asymptomatic carotid stenosis.

Finding

In the stenting trial, the 4-year incidence of stroke or death was significantly lower with stenting plus medical management (2.8%, 95% CI 1.5 to 4.3) compared to medical management alone (6.0%, 95% CI 3.8 to 8.3; P=0.02). In the endarterectomy trial, no significant difference was observed between endarterectomy plus medical management (3.7%, 95% CI 2.1 to 5.5) and medical management alone (5.3%, 95% CI 3.3 to 7.4; P=0.24).

So What?

Clinicians should consider carotid-artery stenting in addition to intensive medical therapy for high-grade asymptomatic carotid stenosis to reduce stroke risk, whereas carotid endarterectomy may not provide significant additional benefit.

Study Type

Systematic review

Context

This study addresses the challenge of accurately differentiating left from right ventricular outflow tract arrhythmias using ECG algorithms prior to ablation.

Finding

The 'Weighted hybrid score' ECG algorithm demonstrated the highest diagnostic accuracy with a superiority index of 21.2 (95% CI 0.3 to 39.0), diagnostic odds ratio of 275.8 (95% CI 7.1 to 1642.5), pooled sensitivity of 0.83 (95% CI 0.53 to 0.98), and specificity of 0.92 (95% CI 0.68 to 0.99).

So What?

Clinicians can improve pre-ablation planning and treatment strategy by using the 'Weighted hybrid score' ECG algorithm to more reliably distinguish LVOT from RVOT arrhythmias.

Study Type

RCT

Context

The study addresses whether achieving very low LDL cholesterol levels reduces the risk of recurrent stroke and major cardiovascular events in patients with previous ischemic stroke.

Finding

Lower achieved LDL-C levels, particularly <40 mg/dL, were associated with significantly reduced incidence of major adverse cardiovascular events and recurrent ischemic stroke without increased hemorrhagic stroke risk; incidence rate ratio for primary endpoint was 0.69 (95% CI, 0.57-0.84) compared to LDL-C ≥70 mg/dL.

So What?

Clinicians should consider more intensive LDL-C lowering strategies in patients with prior ischemic stroke to reduce recurrent events without heightened hemorrhagic stroke risk.

Study Type

Narrative review

Context

Management challenges and treatment strategies for patients with severe aortic stenosis and concomitant multivalvular heart disease.

Finding

Percutaneous interventions for additional valvular lesions are increasingly adopted despite limited randomized evidence; a multidisciplinary approach integrating clinical, hemodynamic, and imaging data is essential for effective treatment planning.

So What?

Clinicians should consider comprehensive evaluation and tailored treatment strategies for multivalvular involvement in aortic stenosis, recognizing the prognostic impact and the evolving role of percutaneous therapies.

Study Type

RCT

Context

This study addresses whether a novel biodegradable patent foramen ovale (PFO) closure device is as effective and safe as traditional nitinol devices for PFO closure.

Finding

The biodegradable device achieved a 90.63% closure success rate at 6 months, noninferior to the 91.49% rate with nitinol devices (lower 95% CI limit of difference -8.98%, above the -10% noninferiority margin); no deaths, embolism, thrombus, or erosion occurred, and the biodegradable device disappeared on echocardiography by 24 months.

So What?

Clinicians can consider the biodegradable PFO closure device as a safe and effective alternative to nitinol devices, with the added benefit of device resorption over time, potentially reducing long-term device-related complications.

Study Type

Retrospective cohort

Context

This study examined whether operator procedural volume is associated with patient outcomes for transcatheter aortic valve replacement (TAVR) and mitral transcatheter edge-to-edge repair (MTEER) in the contemporary era.

Finding

Low-volume TAVR operators (<15/year) had higher 30-day mortality (OR 1.13; 95% CI 1.02-1.26; P=0.02) and in-hospital complications (OR 1.09; 95% CI 1.03-1.16; P=0.005) compared with high-volume operators (>37/year). For MTEER, low-volume operators (<8/year) had higher in-hospital complications (OR 1.31; 95% CI 1.11-1.56; P=0.002) but no significant difference in 30-day mortality (OR 1.16; 95% CI 0.96-1.41; P=0.12).

So What?

Clinicians and policymakers should consider operator procedural volume as an important factor influencing outcomes for TAVR and MTEER, supporting volume thresholds to optimize patient safety and procedural success.

Study Type

Prospective cohort

Context

This study examined how long-term leisure time physical activity relates to plasma protein profiles and subsequent cardiovascular risk and mortality.

Finding

Higher leisure time physical activity over 20 years was inversely associated with 12 plasma proteins; among these, IL-6 was linked to increased imminent MI risk (HR 1.22, 95% CI 1.09-1.37), TNFRSF11A to long-term MI risk (HR 1.22, 95% CI 1.01-1.48), and 11 proteins to increased mortality (HR 1.14-1.30, 95% CI 1.01-1.42).

So What?

Clinicians should recognize that sustained physical activity may confer cardiovascular protection partly through modulation of inflammatory and metabolic proteins, highlighting potential biomarkers for risk stratification and targets for intervention.

Study Type

Prospective cohort

Context

This study addresses the unclear role of long-term insomnia symptom trajectories in the risk of incident cardiovascular disease in older adults.

Finding

Participants with increasing or persistently high insomnia symptom trajectories had significantly higher risk of incident cardiovascular disease compared to those with persistently low symptoms (HR 1.28, 95% CI 1.10 to 1.50 and HR 1.32, 95% CI 1.15 to 1.50, respectively).

So What?

Clinicians should consider both baseline insomnia symptom burden and changes over time as important factors when assessing cardiovascular risk in older adults.